Loading stock…

Concentrix Corporation (CNXC) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Concentrix Corporation

CNXCMarket cap $1.60BPrice $26.2

Country🇺🇸United States

SectorIndustrials

IndustryProfessional Services

Runs customer experience operations for the world's biggest brands, handling everything from tech support to AI training data. Manages over 1 million customer interactions daily across 70+ countries, making it one of the largest CX outsourcers on the planet.

In Bastion Portfolios?

52W Return-40%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+16%8

Revenue Forecast

Rev CAGR (1y)+0%3

Rev CAGR (3y)+3%3

Rev CAGR (5y)+3%3

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2+5%5

EPS Growth Y+3-17%2

Quality

Margins

EBIT Margin6%3

Net Income Margin-24%1

Free Cash Flow Margin5%4

Debt

Net Debt/EBITDA3.62

Efficiency

ROE-78%1

ROA-22%1

Earnings Stability55

GEAR+WEAK15

Overall rating across all five factors

Value

100

Price Multiples

P/E Ratio (Forward)210

P/E Ratio (Forward 3y)310

P/BV0.910

EV Multiples

EV/EBITDA Fwd410

EV/EBIT Fwd510

Yield

Free Cash Flow Yield32.1%10

Dividend Yield5.7%10

Momentum

Short term

1 month return-7%4

3 month return+24%10

YTD return-35%1

Mid term

Price vs 52wHigh56%2

1 year return-43%1

Long term

3 year return-64%1

5 year return-84%1

Risk Shield

Price Risk

Beta1.42

Volatility70%1

Free Cash Flow

Free Cash Flow Margin5%4

Free Cash Flow Yield32.1%10

Quality

ROCE6%4

Earnings Stability55

Net Debt/EBITDA3.62

02Growth

Is it actually growing, and how fast?

CNXCConcentrix

Revenue FY25$9.8B

GROWTH RATING↗

WEAK25 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+16%8

Revenue, next 1Y+0%3

Revenue, next 3Y, CAGR+3%3

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+5%5

EPS growth, FY28E-17%2

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 16%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

WATCH

Revenue grew 16%/yr over the last 3 years; forecasts see it cooling to 3%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 75% of companies worldwide.

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK17 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-7%4

3-month return+24%10

YTD return-35%1

MID & LONG-TERM▾SCORE

% of 52-week high56%2

1-year return-43%1

3-year return-64%1

5-year return-84%1

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+24%).

WATCH

Returns sit at the market level over the past month (-7%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-64% over three years and -84% over five), behind 90% of the market.

It's down 43% over the past year, now 44% below its 52-week high. That is lagging the market.

The stock is underperforming so far this year (-35%).

BOTTOM LINE

Weak Tape

Returns across short and long horizons rank poorly versus the market. Momentum offers no support here; the case has to come from other factors. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Concentrix Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CNXCConcentrix

Revenue FY25$9.8B

GROWTH RATING↗

WEAK25 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+16%8

Revenue, next 1Y+0%3

Revenue, next 3Y, CAGR+3%3

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+5%5

EPS growth, FY28E-17%2

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 16%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

WATCH

Revenue grew 16%/yr over the last 3 years; forecasts see it cooling to 3%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 75% of companies worldwide.

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK17 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-7%4

3-month return+24%10

YTD return-35%1

MID & LONG-TERM▾SCORE

% of 52-week high56%2

1-year return-43%1

3-year return-64%1

5-year return-84%1

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+24%).

WATCH

Returns sit at the market level over the past month (-7%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-64% over three years and -84% over five), behind 90% of the market.

It's down 43% over the past year, now 44% below its 52-week high. That is lagging the market.

The stock is underperforming so far this year (-35%).

BOTTOM LINE

Weak Tape

Returns across short and long horizons rank poorly versus the market. Momentum offers no support here; the case has to come from other factors. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Concentrix Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community